Vol. 3, No. 6 — June 2026Independent since 2024
StandardsFundingMastheadNewsletter

Journal Compound

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Dulaglutide

A once-weekly GLP-1 receptor agonist studied for cardiovascular outcomes in REWIND.

0 pieces

Nothing has been filed here yet. The archive is complete from January 2024 onwards; if you expected a piece to appear on this page, write to letters@journalcompound.com and the desk will look.